Detailed information for compound 409996

Basic information

Technical information
  • TDR Targets ID: 409996
  • Name: cyclopentyl N-[(2S,3S)-3-[4-[[3-methyl-4-(3-m ethylphenyl)piperazin-1-yl]methyl]triazol-1-y l]-1,4-diphenylbutan-2-yl]carbamate
  • MW: 606.8 | Formula: C37H46N6O2
  • H donors: 1 H acceptors: 3 LogP: 6.88 Rotable bonds: 13
    Rule of 5 violations (Lipinski): 2
  • SMILES: O=C(N[C@H]([C@@H](n1nnc(c1)CN1CCN(C(C1)C)c1cccc(c1)C)Cc1ccccc1)Cc1ccccc1)OC1CCCC1
  • InChi: 1S/C37H46N6O2/c1-28-12-11-17-33(22-28)42-21-20-41(25-29(42)2)26-32-27-43(40-39-32)36(24-31-15-7-4-8-16-31)35(23-30-13-5-3-6-14-30)38-37(44)45-34-18-9-10-19-34/h3-8,11-17,22,27,29,34-36H,9-10,18-21,23-26H2,1-2H3,(H,38,44)/t29?,35-,36-/m0/s1
  • InChiKey: NXKYYPYYOUULJN-FDDLKMSXSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • cyclopentyl N-[(1S,2S)-1-benzyl-2-[4-[[3-methyl-4-(m-tolyl)piperazin-1-yl]methyl]triazol-1-yl]-3-phenyl-propyl]carbamate
  • N-[(1S,2S)-1-benzyl-2-[4-[[3-methyl-4-(m-tolyl)-1-piperazinyl]methyl]-1-triazolyl]-3-phenylpropyl]carbamic acid cyclopentyl ester
  • cyclopentyl N-[(2S,3S)-3-[4-[[3-methyl-4-(3-methylphenyl)piperazin-1-yl]methyl]-1,2,3-triazol-1-yl]-1,4-diphenyl-butan-2-yl]carbamate
  • N-[(1S,2S)-1-benzyl-2-[4-[[3-methyl-4-(m-tolyl)piperazino]methyl]triazol-1-yl]-3-phenyl-propyl]carbamic acid cyclopentyl ester
  • cyclopentyl N-[(2S,3S)-3-[4-[[3-methyl-4-(3-methylphenyl)piperazin-1-yl]methyl]triazol-1-yl]-1,4-di(phenyl)butan-2-yl]carbamate
  • cyclopentyl N-[(1S,2S)-2-[4-[[3-methyl-4-(3-methylphenyl)piperazin-1-yl]methyl]triazol-1-yl]-3-phenyl-1-(phenylmethyl)propyl]carbamate
  • N-[(1S,2S)-2-[4-[[3-methyl-4-(3-methylphenyl)-1-piperazinyl]methyl]-1-triazolyl]-3-phenyl-1-(phenylmethyl)propyl]carbamic acid cyclopentyl ester
  • N-[(1S,2S)-1-(benzyl)-2-[4-[[3-methyl-4-(3-methylphenyl)piperazin-1-yl]methyl]triazol-1-yl]-3-phenyl-propyl]carbamic acid cyclopentyl ester
  • cyclopentyl N-[(2S,3S)-3-[4-[[3-methyl-4-(3-methylphenyl)piperazin-1-yl]methyl]-1,2,3-triazol-1-yl]-1,4-di(phenyl)butan-2-yl]carbamate
  • AIDS-470569
  • AIDS470569
  • {1-Benzyl-2-[4-(3-methyl-4-m-tolyl-piperazin-1-ylmethyl)-[1,2,3]triazol-1-yl]-3-phenyl-propyl}-carbamic acid cyclopentyl ester

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium ulcerans dihydrofolate reductase DfrA 0.1119 1 1
Schistosoma mansoni hypothetical protein 0.0016 0.002 0.002
Echinococcus multilocularis dihydrofolate reductase 0.1119 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Echinococcus granulosus dihydrofolate reductase 0.1119 1 1
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0036 0.02 0.0181
Schistosoma mansoni NADP-specific isocitrate dehydrogenase 0.0016 0.002 0.002
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Trypanosoma brucei DNA polymerase IV, putative 0.0019 0.0051 0.0059
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0049 0.0324 0.0305
Echinococcus multilocularis dna polymerase eta 0.0044 0.0279 0.026
Trypanosoma cruzi dihydrofolate reductase-thymidylate synthase 0.0601 0.5313 1
Mycobacterium tuberculosis Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) 0.1119 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Loa Loa (eye worm) transcription factor SMAD2 0.0118 0.0946 0.0928
Schistosoma mansoni hypothetical protein 0.0016 0.002 0.002
Trypanosoma cruzi DNA polymerase eta, putative 0.0044 0.0279 0.0489
Loa Loa (eye worm) hypothetical protein 0.0044 0.0279 0.026
Brugia malayi latrophilin 2 splice variant baaae 0.0034 0.0183 0.0164
Brugia malayi hypothetical protein 0.0036 0.02 0.0181
Echinococcus granulosus dna polymerase kappa 0.0019 0.0051 0.0032
Schistosoma mansoni rab geranylgeranyl transferase alpha subunit 0.0019 0.0051 0.0051
Loa Loa (eye worm) hypothetical protein 0.0034 0.0183 0.0164
Brugia malayi Zinc finger, C2H2 type family protein 0.0306 0.2642 0.2628
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0336 1
Echinococcus multilocularis thymidylate synthase 0.0106 0.0839 0.0821
Echinococcus granulosus thymidylate synthase 0.0106 0.0839 0.0821
Echinococcus multilocularis zinc finger transcription factor gli2 0.0306 0.2642 0.2628
Trypanosoma brucei DNA polymerase eta, putative 0.0044 0.0279 0.0489
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase 0.0601 0.5313 1
Giardia lamblia DINP protein human, muc B family 0.0019 0.0051 0.5
Brugia malayi MH2 domain containing protein 0.0118 0.0946 0.0928
Entamoeba histolytica hypothetical protein 0.0036 0.02 1
Leishmania major DNA polymerase eta, putative 0.0044 0.0279 0.0489
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Mycobacterium leprae DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) 0.1119 1 1
Leishmania major DNA polymerase eta, putative 0.0031 0.016 0.0264
Trypanosoma brucei DNA polymerase IV, putative 0.0019 0.0051 0.0059
Loa Loa (eye worm) dihydrofolate reductase 0.1119 1 1
Onchocerca volvulus 0.0106 0.0839 0.5
Schistosoma mansoni terminal deoxycytidyl transferase 0.0019 0.0051 0.0051
Loa Loa (eye worm) thymidylate synthase 0.0106 0.0839 0.0821
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Loa Loa (eye worm) MH2 domain-containing protein 0.0118 0.0946 0.0928
Schistosoma mansoni bifunctional dihydrofolate reductase-thymidylate synthase 0.0106 0.0839 0.0839
Brugia malayi Dihydrofolate reductase 0.1119 1 1
Mycobacterium tuberculosis Conserved hypothetical protein 0.0019 0.0051 0.0031
Mycobacterium tuberculosis Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) 0.0019 0.0051 0.0031
Trypanosoma cruzi DNA polymerase eta, putative 0.0031 0.016 0.0264
Trypanosoma brucei unspecified product 0.0019 0.0051 0.0059
Loa Loa (eye worm) zinc finger protein 0.0306 0.2642 0.2628
Schistosoma mansoni dihydrofolate reductase 0.1119 1 1
Leishmania major DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Brugia malayi thymidylate synthase 0.0106 0.0839 0.0821
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Brugia malayi hypothetical protein 0.0051 0.0336 0.0316
Trypanosoma brucei DNA polymerase IV, putative 0.0019 0.0051 0.0059
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Brugia malayi Calcitonin receptor-like protein seb-1 0.0049 0.0324 0.0305
Trypanosoma cruzi DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Schistosoma mansoni hypothetical protein 0.0034 0.0183 0.0183
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0036 0.02 0.0181
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0049 0.0324 0.0305
Schistosoma mansoni hypothetical protein 0.0016 0.002 0.002
Echinococcus multilocularis dna polymerase kappa 0.0019 0.0051 0.0032
Leishmania major dihydrofolate reductase-thymidylate synthase 0.0601 0.5313 1
Trypanosoma cruzi dihydrofolate reductase-thymidylate synthase, putative 0.0051 0.0336 0.0596
Echinococcus granulosus dna polymerase eta 0.0044 0.0279 0.026
Echinococcus granulosus zinc finger transcription factor gli2 0.0306 0.2642 0.2628
Echinococcus granulosus terminal deoxycytidyl transferase rev1 0.0019 0.0051 0.0032
Echinococcus multilocularis terminal deoxycytidyl transferase rev1 0.0019 0.0051 0.0032
Schistosoma mansoni hypothetical protein 0.0036 0.02 0.02
Toxoplasma gondii bifunctional dihydrofolate reductase-thymidylate synthase 0.0601 0.5313 1
Mycobacterium ulcerans thymidylate synthase 0.0106 0.0839 0.0792
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0019 0.0051 0.0059
Brugia malayi ImpB/MucB/SamB family protein 0.0019 0.0051 0.0032
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Chlamydia trachomatis dihydrofolate reductase 0.1119 1 0.5
Trypanosoma cruzi DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Entamoeba histolytica hypothetical protein 0.0036 0.02 1
Schistosoma mansoni DNA polymerase eta 0.0044 0.0279 0.0279
Loa Loa (eye worm) ImpB/MucB/SamB family protein 0.0019 0.0051 0.0032
Brugia malayi ImpB/MucB/SamB family protein 0.0044 0.0279 0.026
Entamoeba histolytica hypothetical protein 0.0036 0.02 1
Plasmodium vivax bifunctional dihydrofolate reductase-thymidylate synthase, putative 0.0601 0.5313 1
Mycobacterium tuberculosis Probable thymidylate synthase ThyA (ts) (TSASE) 0.0106 0.0839 0.0821
Entamoeba histolytica hypothetical protein 0.0036 0.02 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Trypanosoma cruzi DNA polymerase kappa, putative 0.0019 0.0051 0.0059
Loa Loa (eye worm) hypothetical protein 0.0049 0.0324 0.0305
Toxoplasma gondii ImpB/MucB/SamB family protein 0.0031 0.016 0.0264
Schistosoma mansoni transcription factor LCR-F1 0.0036 0.02 0.02
Schistosoma mansoni hypothetical protein 0.0016 0.002 0.002
Mycobacterium tuberculosis Hypothetical protein 0.0051 0.0336 0.0316
Trypanosoma brucei dihydrofolate reductase-thymidylate synthase 0.0601 0.5313 1

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) = 55 % Inhibition of HIV1 protease at 5 uM ChEMBL. 17181152
Inhibition (binding) = 55 % Inhibition of HIV1 protease at 5 uM ChEMBL. 17181152

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.